Found: 27
Select item for more details and to access through your institution.
Late‐onset narcolepsy presenting as rapidly progressing muscle weakness: Response to plasmapheresis.
- Published in:
- Annals of Neurology, 2005, v. 58, n. 3, p. 489
- By:
- Publication type:
- Article
Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction to: Changes in Cataplexy Frequency in a Clinical Trial of Lower‑Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
- Published in:
- CNS Drugs, 2022, v. 36, n. 7, p. 785, doi. 10.1007/s40263-022-00933-1
- By:
- Publication type:
- Article
Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
- Published in:
- CNS Drugs, 2022, v. 36, n. 6, p. 633, doi. 10.1007/s40263-022-00926-0
- By:
- Publication type:
- Article
Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A randomized study of solriamfetol for excessive sleepiness in narcolepsy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pro: Modafinil Has a Role in Management of Sleep Apnea.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2003, v. 167, n. 2, p. 105, doi. 10.1164/rccm.2209006
- By:
- Publication type:
- Article
Response to Letter to the Editor Regarding "Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients With Narcolepsy: A Commentary".
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 4, p. 1307, doi. 10.1007/s40120-024-00611-y
- By:
- Publication type:
- Article
Correction: Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 6, p. 1805, doi. 10.1007/s40120-023-00543-z
- By:
- Publication type:
- Article
Correlation of Changes in Patient-Reported Quality of Life With Physician-Rated Global Impression of Change in Patients With Narcolepsy Participating in a Clinical Trial of Sodium Oxybate: A Post Hoc Analysis.
- Published in:
- Neurology & Therapy, 2017, v. 6, n. 2, p. 237, doi. 10.1007/s40120-017-0076-6
- By:
- Publication type:
- Article
Evaluation of Quality of Life in Patients With Narcolepsy Treated With Sodium Oxybate: Use of the 36-Item Short-Form Health Survey in a Clinical Trial.
- Published in:
- Neurology & Therapy, 2016, v. 5, n. 2, p. 203, doi. 10.1007/s40120-016-0053-5
- By:
- Publication type:
- Article
Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia.
- Published in:
- Nature & Science of Sleep, 2022, v. 14, p. 1901, doi. 10.2147/NSS.S369122
- By:
- Publication type:
- Article
Changes in Medical Services and Drug Utilization and Associated Costs After Narcolepsy Diagnosis in the United States.
- Published in:
- American Health & Drug Benefits, 2018, v. 11, n. 3, p. 137
- By:
- Publication type:
- Article
Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Test–retest reliability of the Epworth Sleepiness Scale in clinical trial settings.
- Published in:
- Journal of Sleep Research, 2022, v. 31, n. 2, p. 1, doi. 10.1111/jsr.13476
- By:
- Publication type:
- Article
Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy.
- Published in:
- Journal of Sleep Research, 2017, v. 26, n. 4, p. 407, doi. 10.1111/jsr.12468
- By:
- Publication type:
- Article
Assessing narcolepsy with cataplexy in children and adolescents: development of a cataplexy diary and the ESS-CHAD.
- Published in:
- Nature & Science of Sleep, 2017, v. 9, p. 201, doi. 10.2147/NSS.S140143
- By:
- Publication type:
- Article
Oral pressure therapy for treatment of obstructive sleep apnea: clinical feasibility.
- Published in:
- Nature & Science of Sleep, 2013, v. 5, p. 53, doi. 10.2147/NSS.S44736
- By:
- Publication type:
- Article
Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Effect of Adjunctive Modafinil on Wakefulness and Quality of Life in Patients with Excessive Sleepiness-Associated Obstructive Sleep Apnoea/Hypopnoea Syndrome.
- Published in:
- CNS Drugs, 2007, v. 21, n. 5, p. 407, doi. 10.2165/00023210-200721050-00004
- By:
- Publication type:
- Article
γ-Hydroxybutyrate/Sodium Oxybate: Neurobiology, and Impact on Sleep and Wakefulness.
- Published in:
- CNS Drugs, 2006, v. 20, n. 12, p. 993, doi. 10.2165/00023210-200620120-00004
- By:
- Publication type:
- Article
gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.
- Published in:
- 2006
- By:
- Publication type:
- journal article
The Psychiatric Dimensions of Narcolepsy.
- Published in:
- Psychiatric Times, 2014, v. 31, n. 1, p. 1
- By:
- Publication type:
- Article
A feasibility evaluation of oral pressure therapy for the treatment of obstructive sleep apnea.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2013, v. 7, n. 1, p. 3, doi. 10.1177/1753465812468043
- By:
- Publication type:
- Article
Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease.
- Published in:
- Movement Disorders, 2010, v. 25, n. 14, p. 2296, doi. 10.1002/mds.23348
- By:
- Publication type:
- Article
The Xyrem® (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017.
- Published in:
- Drugs - Real World Outcomes, 2021, v. 8, n. 1, p. 15, doi. 10.1007/s40801-020-00223-6
- By:
- Publication type:
- Article